Literature DB >> 3678271

Neurodevelopmental screening of in utero growth-retarded prematurely born children before school age.

R Matilainen1, K Heinonen, H Siren-Tiusanen, V Jokela, K Launiala.   

Abstract

As part of a prospective follow-up study of two premature cohorts (gestational age less than or equal to 36 weeks) born between 1976 and 1977, designed to evaluate the effects of IUGR on morbidity, mortality and neurological development in prematurely born children, 71 prematurely born children (48 AGA, 23 IUGR) without major neurological handicaps were subjected to detailed assessment of their neurological and psychological status at the age of 4 years. Thirty-six healthy full-term children formed a control group. The socioeconomic status of the families of the premature groups was similar to that of the families of the control group. The assessment consisted of a neurodevelopmental screening test and four psychological tests. Validation of the NDS test in relation to proven cognitive problems (sensitivity 96%, specificity 64%, relative risk 16.74) and determination of normal ranges were based on findings in the control group. There were significantly more children with moderate to high risk scores (greater than or equal to 10) among the IUGR group than among the AGA group. The neurodevelopmental profile of the preterm IUGR group was characterized by complex deviations of motor, visual and perceptual functions from normal. Preterm AGA children had only slightly higher risk scores in relation to fine motor, upper motor and perceptive functions than control children. Of the various perinatal factors studied, IUGR (especially in relation to boys who needed respirator therapy) was the most likely to be associated with abnormal NDS scores before school age.

Entities:  

Mesh:

Year:  1987        PMID: 3678271     DOI: 10.1007/bf00441593

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  25 in total

1.  Estimation of the probability of an event as a function of several independent variables.

Authors:  S H Walker; D B Duncan
Journal:  Biometrika       Date:  1967-06       Impact factor: 2.445

2.  Very low birthweight and later intelligence.

Authors:  J Francis-Williams; P A Davies
Journal:  Dev Med Child Neurol       Date:  1974-12       Impact factor: 5.449

3.  Decreasing incidence of low birth weight diplegia--an achievement of modern neonatal care?

Authors:  B Hagberg; I Olow; G Hagberg
Journal:  Acta Paediatr Scand       Date:  1973-03

4.  Handicap in the preterm small-for-gestational age infant.

Authors:  J O Commey; P M Fitzhardinge
Journal:  J Pediatr       Date:  1979-05       Impact factor: 4.406

5.  Normality and normalization as seen in a long-term neurological follow-up of 286 truly premature infants.

Authors:  S Saint-Anne Dargassies
Journal:  Neuropadiatrie       Date:  1979-08

6.  Considerations in evaluating changes in outcome for infants weighing less than 1,501 grams.

Authors:  H Knobloch; A Malone; P H Ellison; F Stevens; M Zdeb
Journal:  Pediatrics       Date:  1982-03       Impact factor: 7.124

7.  Mortality and morbidity in infants with intrauterine growth retardation.

Authors:  B Starfield; S Shapiro; M McCormick; D Bross
Journal:  J Pediatr       Date:  1982-12       Impact factor: 4.406

8.  Intrauterine growth retardation (IUGR) in pre-term infants.

Authors:  K Heinonen; R Matilainen; H Koski; K Launiala
Journal:  J Perinat Med       Date:  1985       Impact factor: 1.901

9.  Neurological investigation of 5-year-old children with low birthweight.

Authors:  I Bjerre
Journal:  Acta Paediatr Scand       Date:  1975-11

10.  The preterm small-for-gestational age infant: a two-year follow-up study.

Authors:  B R Vohr; W Oh; A G Rosenfield; R M Cowett; J Berstein
Journal:  Am J Obstet Gynecol       Date:  1979-02-15       Impact factor: 8.661

View more
  1 in total

1.  Neurodevelopmental screening of 5-year-old children.

Authors:  K Michelsson; M Donner; E Lindahl
Journal:  Eur J Pediatr       Date:  1988-08       Impact factor: 3.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.